Clinical RoundupFree Keytruda combination improved OS regardless of PD-L1 expression, including patients who tested negative for PD-L1 April 20, 2018Vol.44 No.16
Clinical RoundupFree Keytruda reduced risk of recurrence or death by over 40% vs. placebo as adjuvant therapy in resected, high-risk stage III melanoma April 20, 2018Vol.44 No.16
Clinical RoundupFree SU2C researchers find treatment strategy for stage I-III NSCLC April 20, 2018Vol.44 No.16
Clinical Roundup NCI study revises molecular classification for most common type of lymphoma April 13, 2018Vol.44 No.15
Clinical Roundup Updated ASTRO guideline for lung radiation recommends concurrent chemotherapy for some stage III patients April 13, 2018Vol.44 No.15
Clinical Roundup Keytruda monotherapy meets OS endpoint in phase III trial April 13, 2018Vol.44 No.15
Clinical Roundup Epacadostat plus Keytruda don’t meet PFS endpoint in phase III study in metastatic melanoma April 13, 2018Vol.44 No.15
Clinical Roundup Roswell Park, Ohio State researchers identify genes linked to blood and marrow transplant outcomes April 13, 2018Vol.44 No.15
Clinical RoundupFree NIH completes in-depth genomic analysis of 33 cancer types April 06, 2018Vol.44 No.14
Clinical RoundupFree Simultaneous chemo and immunotherapy may be better for some metastatic bladder cancers April 06, 2018Vol.44 No.14
